Present-day investigations cannot adequately determine the risk of acute coronary syndromes

R S Foo1

  • 1Clinical Pharmacology Unit, University of Cambridge, UK. rf226@medschl.cam.ac.uk

Clinical Laboratory
|June 19, 2001
PubMed

Insights

Current stress tests cannot identify vulnerable plaques. Pathological studies reveal plaque content, not size, determines rupture risk, offering targets for new detection methods.

Area of Science:

  • Cardiology
  • Pathology
  • Biomedical Engineering

Background:

  • Clinical stress testing (e.g., exercise electrocardiogram, stress echocardiography, coronary angiography) fails to detect vulnerable coronary plaques.
  • Vulnerable plaques, a key factor in acute coronary syndromes, are often invisible to current imaging techniques.
  • Pathological studies highlight thrombosis and plaque composition as critical in acute coronary syndromes.

Purpose of the Study:

  • To emphasize the limitations of current stress testing in identifying vulnerable plaques.
  • To highlight the importance of plaque content (lipid core, thin cap) over plaque size in determining rupture risk.
  • To identify cellular and molecular features of vulnerable plaques as potential targets for new diagnostic and therapeutic strategies.

Main Methods:

  • Review of landmark pathological studies on acute coronary syndromes.
  • Analysis of angioscopic and necropsy findings regarding plaque rupture and thrombosis.
  • Comparison of information obtained from clinical stress tests versus pathological plaque characteristics.

Main Results:

  • Vulnerable plaques, characterized by a thin fibrous cap and large lipid core, are not visualized by standard stress tests.
  • Plaque rupture is associated with specific cellular components (macrophages, T-lymphocytes) and enzymatic activity (matrix metalloproteinases).
  • Downregulation of smooth muscle cell proliferation and collagen synthesis is observed in vulnerable plaques.

Conclusions:

  • Clinical stress testing primarily assesses plaque size, not the composition that dictates rupture risk.
  • Features of vulnerable plaques, such as thin caps, lipid cores, and inflammatory cell infiltration, are key targets for future diagnostic tools.
  • Understanding these pathological features may lead to novel methods for detecting and potentially reversing the risk associated with vulnerable plaques.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...